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Résumé en
anglais
The aim of this study was to further characterize the conformational neutralizing
epitopes present on the surface-exposed FG loop of human papillomavirus (HPV)
type 16 L1 major capsid protein. We have generated previously two chimeric L1
proteins by insertion of a foreign peptide encoding an epitope of the hepatitis B core
(HBc) antigen within the FG loop. In addition, three other chimeric L1 proteins were
obtained by replacing three different FG loop sequences by the HBc motif and three
others by point mutations. All these chimeric L1 proteins retained the ability to self-
assemble into virus-like particles (VLPs), with the exception of the mutant with
substitution of the L1 sequence 274-279 by the HBc motif. The eight chimeric VLPs
were then analyzed for differential reactivity with a set of six HPV-16 and HPV-31
monoclonal antibodies that bound to conformational and linear epitopes. The binding
patterns of these monoclonal antibodies confirmed that the FG loop contained or
contributed to neutralizing conformational epitopes. The results obtained suggested
that the H31.F7 antibody, an anti-HPV-31 cross-reacting and neutralizing antibody,
recognized a conformational epitope situated before the 266-271 sequence. In
addition, H16.E70 neutralizing antibody reactivity was reduced with L1 VLPs with an
Asn to Ala point mutation at position 270, suggesting that Asn is a part of the
epitope recognized by this antibody. This study contributes to the understanding of
the antigenic structure of HPV-16 and -31 L1 proteins by confirming that the FG loop
contributes to neutralizing epitopes and suggesting the existence of both type-
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